PUBLIC POLICY

Texas is one of the leading life science states in the country and continues to outpace national growth for the industry. We must continue to protect and grow the life science industry in this state.

Did you know:

• Texas is home to more than 5,500 life science businesses and 228,353 employees in related ﬁelds (2018)

• Academic R&D Expenditures of nearly $3.3 billion (2016)

• Nearly $1.2 billion in NIH Funding (2017)

• 4,704 patent awards to Texas inventors (2014-2017)

• $1.5 Billion in bioscience venture capital investments (2014-2017)

THBI LEGISLATIVE PRIORITIES

Access to Innovation

THBI is committed to safeguarding and preserving timely patient access to new medicines while maintaining the integrity of those who utilize the latest innovations in creating these products.

Research & Development

The Texas life sciences industry supports private-public collaborations that will allow Texas to compete globally and also supports efforts to build and sustain a highly skilled technology workforce in the state.

Higher Education

THBI support the Governor’s University Research Initiative Grant Program (GURI) as Texas continues to recruit the best and brightest in the world to Texas.

CPRIT

Cancer Prevention & Research Institute of Texas (CPRIT) continues to foster cancer research and prevention in Texas as well as fund product development. THBI supports the funding and agency reauthorization for CPRIT for another 10 years.

THBI End of Session Report

THBI released its End of Session Report for the 86th Regular Session.

View Report

THBI and 69 State Bio Organizations Commend the US Administration on United States-Mexico-Canada Agreement (USMCA)

"We are encouraged by the progress made toward establishing vital intellectual property (IP) protections. These new standards will drive investment, innovation, exports, and bioscience job creation for U.S. innovators – the lifeblood of America’s economy. This agreement raises standards for trade policy, particularly in the life sciences sector, and sets high minimum standards and expectations for our trading partners to value American innovation."

View Letter of Support

View Press Release